Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000066

Director bought 149,075 shares at an average $10.21 ($1,522,517)

From the SEC's structured data for this filing

Trades in this filing

SPRINGER TIMOTHY A · Director

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-09 Purchase : show line 1 in the form +7,342 $9.43 $69,209 8,628,667 D
2025-04-09 Purchase : show line 2 in the form +31 $9.95 $308 8,628,698 D
2025-04-09 Purchase : show line 3 in the form +41,604 $9.43 $392,176 571,402 I
2025-04-09 Purchase : show line 4 in the form +178 $9.95 $1,771 571,580 I
2025-04-10 Purchase : show line 5 in the form +7,966 $10.43 $83,121 8,636,664 D
2025-04-10 Purchase : show line 6 in the form +609 $10.92 $6,652 8,637,273 D
2025-04-10 Purchase : show line 7 in the form +45,144 $10.43 $471,055 616,724 I
2025-04-10 Purchase : show line 8 in the form +3,451 $10.92 $37,696 620,175 I
2025-04-11 Purchase : show line 9 in the form +6,412 $10.77 $69,074 8,643,685 D
2025-04-11 Purchase : show line 10 in the form +36,338 $10.77 $391,455 656,513 I
Open-market purchases · 149,075 sh · avg $10.21 · $1,522,517
Loading xslF345X05/wk-form4_1744406973.xml…